SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: GREENLAW4-7 who wrote (16965)12/29/2001 7:25:08 PM
From: seminole  Respond to of 99280
 
<<< Price of IMCL was a direct result of market pricing in FDA approval for 2002. >>>

The expected timing of approval is just one component of the price move.
BMY purchase of IMCL shares is another equally important component.
The probability of approval of a Phase III drug with fast track is another component.

I have no position in IMCL (unless it is in FBIOX).
If BTK is the biggest bubble, you should short it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News